Business Description
ShareHope Medicine Co Ltd
ISIN : TW0008403007
Compare
Compare
Traded in other countries / regions
8403.Taiwan IPO Date
2011-03-01Description
ShareHope Medicine Co Ltd is engaged in providing wholesale and retail sales of medicines and hygiene materials, leasing assets for medical institutions to undertake related medical services and physical examinations for Taiwanese people and foreign laborers, on-site medical support services, hemodialysis business management, and ophthalmic medical management in collaboration with medical institutions. The company also provides a pharmaceutical procurement platform for medicines, health materials, and home care products. The company's revenue mainly stems from medicine and medical material sales, alongside service income from physical examinations for Taiwanese citizens and foreign laborers, on-site medical support, hemodialysis management, and ophthalmic collaborations.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.61 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.61 | |||||
| Debt-to-EBITDA | 4.45 | |||||
| Interest Coverage | 2.22 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.69 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.1 | |||||
| 3-Year EBITDA Growth Rate | -11.3 | |||||
| 3-Year EPS without NRI Growth Rate | -19.8 | |||||
| 3-Year Book Growth Rate | 6.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.65 | |||||
| 9-Day RSI | 60.68 | |||||
| 14-Day RSI | 56.45 | |||||
| 6-1 Month Momentum % | -2.74 | |||||
| 12-1 Month Momentum % | -15.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.71 | |||||
| Quick Ratio | 1.55 | |||||
| Cash Ratio | 0.72 | |||||
| Days Inventory | 33.97 | |||||
| Days Sales Outstanding | 114.46 | |||||
| Days Payable | 74.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.55 | |||||
| Dividend Payout Ratio | 0.56 | |||||
| Forward Dividend Yield % | 1.55 | |||||
| 5-Year Yield-on-Cost % | 1.55 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 9.1 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.5 | |||||
| Operating Margin % | 3.1 | |||||
| Net Margin % | 2.83 | |||||
| FCF Margin % | 4.57 | |||||
| ROE % | 3.21 | |||||
| ROA % | 1.53 | |||||
| ROIC % | 1.23 | |||||
| ROC (Joel Greenblatt) % | 6.01 | |||||
| ROCE % | 2.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.71 | |||||
| PE Ratio without NRI | 36.39 | |||||
| Shiller PE Ratio | 17.38 | |||||
| Price-to-Owner-Earnings | 62.38 | |||||
| PEG Ratio | 3.6 | |||||
| PS Ratio | 1.02 | |||||
| PB Ratio | 1.14 | |||||
| Price-to-Tangible-Book | 1.26 | |||||
| Price-to-Free-Cash-Flow | 22.12 | |||||
| Price-to-Operating-Cash-Flow | 10.99 | |||||
| EV-to-EBIT | 30.33 | |||||
| EV-to-EBITDA | 10.1 | |||||
| EV-to-Revenue | 1.23 | |||||
| EV-to-FCF | 26.78 | |||||
| Price-to-Projected-FCF | 1.26 | |||||
| Price-to-DCF (Earnings Based) | 3.15 | |||||
| Price-to-DCF (FCF Based) | 1.92 | |||||
| Price-to-Median-PS-Value | 0.95 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.2 | |||||
| Price-to-Graham-Number | 1.43 | |||||
| Earnings Yield (Greenblatt) % | 3.3 | |||||
| FCF Yield % | 4.45 | |||||
| Forward Rate of Return (Yacktman) % | 7.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ShareHope Medicine Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 3,949.675 | ||
| EPS (TTM) (NT$) | 0.877 | ||
| Beta | 0.23 | ||
| Volatility % | 16.1 | ||
| 14-Day RSI | 56.45 | ||
| 14-Day ATR (NT$) | 0.380068 | ||
| 20-Day SMA (NT$) | 31.9725 | ||
| 12-1 Month Momentum % | -15.37 | ||
| 52-Week Range (NT$) | 30.5 - 40.428571 | ||
| Shares Outstanding (Mil) | 126.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ShareHope Medicine Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ShareHope Medicine Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
ShareHope Medicine Co Ltd Frequently Asked Questions
What is ShareHope Medicine Co Ltd(ROCO:8403)'s stock price today?
The current price of ROCO:8403 is NT$32.20. The 52 week high of ROCO:8403 is NT$40.43 and 52 week low is NT$30.50.
When is next earnings date of ShareHope Medicine Co Ltd(ROCO:8403)?
The next earnings date of ShareHope Medicine Co Ltd(ROCO:8403) is .
Does ShareHope Medicine Co Ltd(ROCO:8403) pay dividends? If so, how much?
The Dividend Yield %  of ShareHope Medicine Co Ltd(ROCO:8403) is 1.55% (As of Today), Highest Dividend Payout Ratio of ShareHope Medicine Co Ltd(ROCO:8403) was 0.9. The lowest was 0.15. And the median was 0.29. The  Forward Dividend Yield % of ShareHope Medicine Co Ltd(ROCO:8403) is 1.55%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers